MY132819A - Pharmaceutical compositions containing n-sulphonylindoline derivatives - Google Patents
Pharmaceutical compositions containing n-sulphonylindoline derivativesInfo
- Publication number
- MY132819A MY132819A MYPI97005848A MYPI9705848A MY132819A MY 132819 A MY132819 A MY 132819A MY PI97005848 A MYPI97005848 A MY PI97005848A MY PI9705848 A MYPI9705848 A MY PI9705848A MY 132819 A MY132819 A MY 132819A
- Authority
- MY
- Malaysia
- Prior art keywords
- amphiphilic
- sulphonylindoline
- nonionic hydrophilic
- derivatives
- surfactant
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000004094 surface-active agent Substances 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000002433 hydrophilic molecules Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000007928 solubilization Effects 0.000 abstract 1
- 238000005063 solubilization Methods 0.000 abstract 1
- 230000003381 solubilizing effect Effects 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
THE PRESENT INVENTION RELATES TO AN ANHYDROUS SOLUBILIZING/STABILIZING SYSTEM WHICH IS EMULSIFIABLE OR MICROEMULSIFIABLE IN WATER, FOR THE SOLUBILIZATION OF HYDROPHOBIC DERIVATIVES OF N-SULPHONYLINDOLINE OF FORMULA:(FORMULA 1)CHARACTERIZED IN THAT IT COMPRISES ONE OR MORE CONSTITUENTS SELECTED FROM AMPHIPHILIC COMPOUNDS, NONIONIC HYDROPHILIC SURFACTANTS AND NONIONIC HYDROPHILIC COMPOUNDS ENDOWED WITH BOTH AMPHIPHILIC AND SURFACTANT PROPERTIES, IT BEING UNDERSTOOD THAT THE SAID SYSTEM COMPRISES EITHER AT LEAST ONE MIXTURE OF AN AMPHIPHILIC COMPOUND AND OF A NONIONIC HYDROPHILIC SURFACTANT,OR AT LEAST ONE NONIONIC HYDROPHILIC COMPOUND ENDOWED WITH BOTH SURFACTANT AND AMPHIPHILIC PROPERTIES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9614957A FR2756736B1 (en) | 1996-12-05 | 1996-12-05 | PHARMACEUTICAL COMPOSITIONS CONTAINING N-SULFONYL INDOLINE DERIVATIVES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY132819A true MY132819A (en) | 2007-10-31 |
Family
ID=9498376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI97005848A MY132819A (en) | 1996-12-05 | 1997-12-04 | Pharmaceutical compositions containing n-sulphonylindoline derivatives |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0941090A1 (en) |
| JP (1) | JP2000507618A (en) |
| KR (1) | KR20000069308A (en) |
| CN (1) | CN1239887A (en) |
| AR (1) | AR009651A1 (en) |
| AU (1) | AU716575B2 (en) |
| BR (1) | BR9712406A (en) |
| CA (1) | CA2273990A1 (en) |
| CO (1) | CO4910129A1 (en) |
| DZ (1) | DZ2362A1 (en) |
| EE (1) | EE9900206A (en) |
| FR (1) | FR2756736B1 (en) |
| HU (1) | HUP0001386A3 (en) |
| ID (1) | ID23373A (en) |
| IL (1) | IL129936A0 (en) |
| IS (1) | IS5062A (en) |
| MY (1) | MY132819A (en) |
| NO (1) | NO992724L (en) |
| NZ (1) | NZ335750A (en) |
| RU (1) | RU2174394C2 (en) |
| SK (1) | SK75599A3 (en) |
| TR (1) | TR199901702T2 (en) |
| WO (1) | WO1998024430A1 (en) |
| YU (1) | YU23099A (en) |
| ZA (1) | ZA9710919B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2786486B3 (en) * | 1998-11-16 | 2000-12-08 | Sanofi Sa | PROCESS FOR THE PREPARATION OF (2S) -1 - [(2R, 3S) -5-CHLORO-3- (2- CHLOROPHENYL) -1- (3,4-DIMETHOXY BENZENESULFONYL) -3-HYDROXY- 2,3-DIHYDRO- 1H-INDOLE-2-CARBONYL] PYRROLIDINE-2-CARBOXAMIDE, ITS SOLVATES AND / OR HYDRATES |
| DE19913692A1 (en) * | 1999-03-25 | 2000-09-28 | Basf Ag | Mechanically stable pharmaceutical dosage forms containing liquid or semi-solid surface-active substances |
| US6437006B1 (en) | 1999-09-27 | 2002-08-20 | American Cyanamid Company | Pharmaceutical carrier formulation |
| US7364752B1 (en) | 1999-11-12 | 2008-04-29 | Abbott Laboratories | Solid dispersion pharamaceutical formulations |
| WO2001034119A2 (en) | 1999-11-12 | 2001-05-17 | Abbott Laboratories | Inhibitors of crystallization in a solid dispersion |
| FR2805992A1 (en) * | 2000-03-08 | 2001-09-14 | Sanofi Synthelabo | Oral administration of N-sulfonyl-indoline derivative to treat central nervous system, cardiovascular or gastric disorders, using polyethylene glycol, polysorbate and poloxamer as solubilizers for high bioavailability |
| DE10026698A1 (en) | 2000-05-30 | 2001-12-06 | Basf Ag | Self-emulsifying active ingredient formulation and use of this formulation |
| ITMI20011338A1 (en) * | 2001-06-26 | 2002-12-26 | Farmatron Ltd | ORAL PHARMACEUTICAL COMPOSITIONS WITH IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| UA119324C2 (en) * | 2013-04-02 | 2019-06-10 | Теміс Медікер Лімітед | Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives |
| KR102139339B1 (en) * | 2013-06-24 | 2020-07-29 | 주식회사 엘지생활건강 | Cosmetic composition which has improved solubility comprising indole compound |
| KR102139338B1 (en) * | 2013-06-24 | 2020-07-29 | 주식회사 엘지생활건강 | Cosmetic composition which has improved solubility comprising indole compound |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3237814A1 (en) * | 1982-10-12 | 1984-04-12 | Warner-Lambert Co., 07950 Morris Plains, N.J. | WATER-FREE EMULSIONS AND USE THEREOF |
| FR2679903B1 (en) * | 1991-08-02 | 1993-12-03 | Elf Sanofi | DERIVATIVES OF N-SULFONYL INDOLINE CARRYING AN AMIDIC FUNCTION, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME. |
-
1996
- 1996-12-05 FR FR9614957A patent/FR2756736B1/en not_active Expired - Fee Related
-
1997
- 1997-12-03 DZ DZ970212A patent/DZ2362A1/en active
- 1997-12-04 CA CA002273990A patent/CA2273990A1/en not_active Abandoned
- 1997-12-04 MY MYPI97005848A patent/MY132819A/en unknown
- 1997-12-04 ID IDW990445D patent/ID23373A/en unknown
- 1997-12-04 TR TR1999/01702T patent/TR199901702T2/en unknown
- 1997-12-04 EE EEP199900206A patent/EE9900206A/en unknown
- 1997-12-04 KR KR1019997004983A patent/KR20000069308A/en not_active Ceased
- 1997-12-04 RU RU99114019/14A patent/RU2174394C2/en active
- 1997-12-04 HU HU0001386A patent/HUP0001386A3/en unknown
- 1997-12-04 JP JP10525294A patent/JP2000507618A/en active Pending
- 1997-12-04 NZ NZ335750A patent/NZ335750A/en unknown
- 1997-12-04 CO CO97071118A patent/CO4910129A1/en unknown
- 1997-12-04 CN CN97180304A patent/CN1239887A/en active Pending
- 1997-12-04 AR ARP970105696A patent/AR009651A1/en unknown
- 1997-12-04 IL IL12993697A patent/IL129936A0/en unknown
- 1997-12-04 AU AU53262/98A patent/AU716575B2/en not_active Ceased
- 1997-12-04 ZA ZA9710919A patent/ZA9710919B/en unknown
- 1997-12-04 EP EP97950228A patent/EP0941090A1/en not_active Withdrawn
- 1997-12-04 SK SK755-99A patent/SK75599A3/en unknown
- 1997-12-04 WO PCT/FR1997/002210 patent/WO1998024430A1/en not_active Ceased
- 1997-12-04 BR BR9712406-0A patent/BR9712406A/en unknown
-
1999
- 1999-05-26 YU YU23099A patent/YU23099A/en unknown
- 1999-06-01 IS IS5062A patent/IS5062A/en unknown
- 1999-06-04 NO NO992724A patent/NO992724L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998024430A1 (en) | 1998-06-11 |
| ID23373A (en) | 2000-04-20 |
| FR2756736A1 (en) | 1998-06-12 |
| NO992724D0 (en) | 1999-06-04 |
| RU2174394C2 (en) | 2001-10-10 |
| TR199901702T2 (en) | 1999-09-21 |
| CA2273990A1 (en) | 1998-06-11 |
| EP0941090A1 (en) | 1999-09-15 |
| BR9712406A (en) | 1999-08-31 |
| CN1239887A (en) | 1999-12-29 |
| AR009651A1 (en) | 2000-04-26 |
| DZ2362A1 (en) | 2002-12-28 |
| CO4910129A1 (en) | 2000-04-24 |
| SK75599A3 (en) | 2000-08-14 |
| IL129936A0 (en) | 2000-02-29 |
| AU5326298A (en) | 1998-06-29 |
| EE9900206A (en) | 1999-12-15 |
| NO992724L (en) | 1999-06-04 |
| NZ335750A (en) | 2001-06-29 |
| ZA9710919B (en) | 1999-06-04 |
| AU716575B2 (en) | 2000-03-02 |
| HUP0001386A2 (en) | 2001-04-28 |
| JP2000507618A (en) | 2000-06-20 |
| FR2756736B1 (en) | 1999-03-05 |
| YU23099A (en) | 1999-11-22 |
| KR20000069308A (en) | 2000-11-25 |
| IS5062A (en) | 1999-06-01 |
| HUP0001386A3 (en) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1997030677A3 (en) | Pentafluorobenzenesulfonamides and analogs | |
| FI964624A0 (en) | Procedure for Stabilization of Duocarmycin Derivatives | |
| SG49049A1 (en) | 5-(-2-Imidazolinylamino) benzimidazole derivatives their preparation and their use as alpha-2 adrenoceptor agonists | |
| CA2129288A1 (en) | Phosphonooxymethyl Esters of Taxane Derivatives | |
| BR0208794A (en) | Low foaming / defoaming compositions containing quaternary ammonium alkoxylated compounds | |
| MX9301032A (en) | PHARMACEUTICAL COMPOUNDS AND PROCEDURE FOR THE PREPARATION | |
| EP0693285A3 (en) | Pharmaceutical compositions containing a bisphosphonate and an anti-resorptive agent for inhibiting bone loss | |
| AU698744B2 (en) | Oil-in-water emulsions | |
| AU6202299A (en) | Compositions for the treatment and prevention of neurological and pathopsychological diseases | |
| NO992724L (en) | Pharmaceutical mixtures containing N-sulfonyl-indoline derivatives | |
| IL163865A0 (en) | Compositions comprising a non-ionicsurfactant and n-docosanol | |
| DE3364588D1 (en) | Fungicidal agent | |
| AU4607899A (en) | Ectoparasiticide agents | |
| MY128392A (en) | 6ALPHA, 9ALPHA-DIFLUORO-17ALPHA-(2-FURANYLCARBOXYL)OXY]-11ß-HYDROXY-16ALPHA-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT | |
| EP0638078A4 (en) | Avermectin difluoro derivatives. | |
| MX9606565A (en) | Bleaching compositions. | |
| AU2881399A (en) | N1-modified glycopeptides | |
| PT1128820E (en) | FRAMACEUTIC MIX UNDERSTANDING A COMBINATION OF PROFEN AND OTHER ACTIVE COMPOUNDS | |
| TNSN97173A1 (en) | PEPTIDE ANALOGS OF LH-RH, THEIR USES AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. | |
| MA23404A1 (en) | OIL-IN-WATER EMULSION | |
| AU4435093A (en) | Methods and agents for combating cockroaches | |
| GB2338416A (en) | Sanitizing composition and method | |
| MX9706845A (en) | Solid diacyl organic peroxide dispersions. | |
| IT1255696B (en) | Compound having vasodilatory activity, process for its preparation and pharmaceutical compositions containing it. | |
| IT1258818B (en) | Oral pharmaceutical compositions based on calcium N<5>- methyltetrahydrofolate |